Literature DB >> 22042507

Primary mucinous adenocarcinoma of the bladder: complete response with FOLFOX-4 regimen.

A M Tatli1, M Uysal, S S Goksu, D Arslan, S Gunduz, M Ozdogan, H S Coskun, H Bozcuk, B Savas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22042507     DOI： 10.1007/s12032-011-0090-y

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  12 in total

1.  Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients.

Authors:  Mohamed S Zaghloul; Akram Nouh; Mohamed Nazmy; Samy Ramzy; Ashraf S Zaghloul; Mohamed Abou Sedira; Ehab Khalil
Journal:  Urol Oncol       Date:  2006 Jan-Feb       Impact factor: 3.498

Review 2.  Intestinal metaplasia is not a strong risk factor for bladder cancer: study of 53 cases with long-term follow-up.

Authors:  F A Corica; D A Husmann; B M Churchill; R H Young; A Pacelli; A Lopez-Beltran; D G Bostwick
Journal:  Urology       Date:  1997-09       Impact factor: 2.649

3.  Sustained response of adenocarcinoma of the urinary bladder to FOLFOX plus bevacizumab.

Authors:  Minyuen Teo; Niall C Swan; Ray S McDermott
Journal:  Nat Rev Urol       Date:  2011-04-12       Impact factor: 14.432

4.  Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.

Authors:  H L Wang; D W Lu; L M Yerian; N Alsikafi; G Steinberg; J Hart; X J Yang
Journal:  Am J Surg Pathol       Date:  2001-11       Impact factor: 6.394

5.  Metastatic urachal cancer responding to FOLFOX chemotherapy.

Authors:  Ben Tran; Joe McKendrick
Journal:  Can J Urol       Date:  2010-04       Impact factor: 1.344

6.  Adenocarcinoma of urinary bladder: classification and management.

Authors:  A L Burnett; J I Epstein; F F Marshall
Journal:  Urology       Date:  1991-04       Impact factor: 2.649

7.  Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma.

Authors:  R Torenbeek; J H Lagendijk; P J Van Diest; H Bril; F J van de Molengraft; C J Meijer
Journal:  Histopathology       Date:  1998-01       Impact factor: 5.087

8.  Primary adenocarcinoma of bladder.

Authors:  T G Wilson; T R Pritchett; G Lieskovsky; N E Warner; D G Skinner
Journal:  Urology       Date:  1991-09       Impact factor: 2.649

9.  Primary adenocarcinoma of the urinary bladder. A clinicopathologic and prognostic study.

Authors:  C Anderström; S L Johansson; L von Schultz
Journal:  Cancer       Date:  1983-10-01       Impact factor: 6.860

Review 10.  Signet-ring cell adenocarcinoma of bladder.

Authors:  L Fiter; F Gimeno; L Martin; L Gómez Tejeda
Journal:  Urology       Date:  1993-01       Impact factor: 2.649
View more
  4 in total

1.  Primary Mucinous Adenocarcinoma of the Urinary Bladder with Signet-Ring Cells: Description of an Uncommon Case and Critical Points in Its Management.

Authors:  Fabrizio Di Maida; Giuliano Amorim Aita; Daniele Amorim Aita
Journal:  Case Rep Urol       Date:  2016-12-18

2.  Advanced primary nonurachal adenocarcinoma of urinary bladder responding to modified FOLFOX6 and capecitabine: a case report.

Authors:  Frank S Fan; Chung-Fan Yang
Journal:  Oxf Med Case Reports       Date:  2018-08-11

3.  Imaging features of primary mucinous adenocarcinoma of bladder outlet and urethra: a case report and literature review.

Authors:  Dawei Wang; Keping Zhang; Lihui Guan; Nuan Wen
Journal:  Transl Cancer Res       Date:  2022-07       Impact factor: 0.496

Review 4.  Urothelial carcinoma of the bladder with abundant myxoid stroma: A case report and literature review.

Authors:  Ting-Ting Tao; Jun Chen; Qing Hu; Xiao-Jun Huang; Jun Fu; Bo-Dong Lv; Yue Duan
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.